PRE 14A

Proxy Statement (Preliminary)

Prime Medicine, Inc. Filed 2025-07-02 Acc 0001193125-25-155000

Documents 1

PRE 14A Proxy Statement (Preliminary) , d87905dpre14a.htm

Around this filing

2025-07-02 PRE 14A Proxy Statement (Preliminary)
2025-07-01 4 10% owner bought 21,000 shares at $2.52 ($52,830)
2024-04-19 PRE 14A Proxy Statement (Preliminary)

Link to a passage

External

SEC EDGAR (opens in new tab)